封面
市場調查報告書
商品編碼
1611906

3D 細胞培養市場:按產品、應用和最終用戶分類 - 2025-2030 年全球預測

3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年3D細胞培養市場規模為19億美元,預計2024年將達20.4億美元,複合年成長率為7.63%,2030年將達31.9億美元。

在類似活體的環境中培養活細胞的創新技術對於生物醫學研究的進步至關重要。與傳統的 2D 培養相比,它能夠在藥物發現、癌症研究和組織工程方面提供更準確的預測資料,從而滿足了其需求。 3D細胞培養的發展跨越了廣泛的領域,包括藥物開發、基因研究、再生醫學和個人化治療。最終用途領域包括生物技術、學術機構、醫院和診斷實驗室。慢性疾病的增加和細胞培養技術的進步是推動市場成長的關鍵因素。此外,腫瘤學研究中擴大採用 3D 培養來研究腫瘤環境也帶來了巨大的成長機會。市場上的最新機會包括晶片器官模型和微流體技術的開發,這可以透過提供更可靠和合乎道德的動物測試替代方案來徹底改變藥物發現和測試。然而,高成本、技術複雜性和缺乏標準化通訊協定等限制是市場成長的主要障礙。此外,需要專門的人力資源來解釋複雜的資料仍然是一個挑戰。技術創新的最佳部分包括探索無骨架系統以及整合人工智慧以增強資料分析和預測建模。對新型骨骼生物材料和增強成像技術的研究可能會進一步擴大市場。投資者和公司應專注於與學術機構的策略夥伴關係,以實現尖端創新,並投資可擴展的技術以降低成本。總體而言,3D細胞培養市場的特點是快速發展和創新,市場競爭激烈,需要企業敏捷性和前瞻性策略,以利用新興趨勢並推動成長。能夠駕馭複雜情況並提供全面解決方案的公司將處於有利地位,能夠充分利用不斷擴大的市場機會。

主要市場統計
基準年[2023] 19億美元
預計年份 [2024] 20.4億美元
預測年份 [2030] 31.9億美元
複合年成長率(%) 7.63%

市場動態:揭示快速發展的 3D 細胞培養市場的關鍵市場洞察

供需的動態交互作用正在改變 3D 細胞培養市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地越來越重視再生醫學
    • 利用 3D 細胞培養進行抗藥性和藥物重新定位
    • 增加細胞研發活動及投資
  • 市場限制因素
    • 3D 細胞培養開發所需的高成本和複雜的基礎設施
  • 市場機會
    • 3D細胞培養技術的進步支持精準醫療
    • 人們對晶片器官模型的認知與採用不斷增強
  • 市場問題
    • 3D 細胞培養的可擴展性有限且缺乏標準化

波特五力:駕馭 3D 細胞培養市場的策略工具

波特的五力架構是了解 3D 細胞培養市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解 3D 細胞培養市場的外部影響

外部宏觀環境因素在塑造 3D 細胞培養市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析:了解 3D 細胞培養市場的競爭格局

對 3D 細胞培養市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣:3D 細胞培養市場供應商績效評估

FPNV定位矩陣是評估3D細胞培養市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議:繪製 3D 細胞培養市場的成功之路

對於想要加強在全球市場的影響力的公司來說,對 3D 細胞培養市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰,利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率:詳細檢視當前市場環境,主要企業的廣泛資料,評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有細分市場的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品和地區提供最佳投資機會?

3.塑造市場的關鍵技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 再生醫學越來越受到世界各國的關注
      • 利用 3D 細胞培養進行抗藥性和藥物重新定位
      • 增加細胞研究的研發活動與投資
    • 抑制因素
      • 3D 細胞培養開發成本高且基礎設施需求複雜
    • 機會
      • 支持精準醫療的 3D 細胞培養技術的進步
      • 人們對晶片器官模型的認知與採用不斷增強
    • 任務
      • 可擴展性有限且 3D 細胞培養非標準化
  • 市場區隔分析
    • 產品:品質優勢和功能增加了無支架 3D 細胞培養的採用
    • 應用:增加3D細胞培養在藥物發現的應用,以維持藥物療效
    • 最終用戶:在實驗室採用 3D 細胞培養技術來了解細胞行為
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第 6 章 3D 細胞培養市場:依產品

  • 介紹
  • 3D生物列印
  • 磁浮
  • 基於微流體的 3D 細胞培養
  • 基於支架的 3D 細胞培養
  • 無支架 3D 細胞培養

第 7 章 3D 細胞培養市場:依應用分類

  • 介紹
  • 癌症
  • 藥物發現
  • 幹細胞研究
  • 組織工程與再生醫學
  • 毒理學

第 8 章 3D 細胞培養市場:依最終使用者分類

  • 介紹
  • 製藥和生物技術公司
  • 實驗室/研究所

第 9 章美洲 3D 細胞培養市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太3D細胞培養市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的3D細胞培養市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • Amsbio 宣布 mCollaFibR:3D 細胞培養的創新
    • 富士軟片宣布斥資 12 億美元在北卡羅來納州擴建,以增強細胞培養能力
    • Molecular Devices 宣布推出 CellXpress.ai 自動化細胞培養系統,這是一個用於快速、可靠藥物發現的 3D 生物學創新中心
    • InSphero 和 Advanced BioMatrix 簽署分銷協議,將 3D 細胞培養應用擴展到基於支架的模型
    • 3D BioFibR 推出兩款 CollaFibR 組織工程產品,進軍生物列印與 3D 細胞培養市場
  • 戰略分析和建議

公司名單

  • 3D BIoTek, LLC
  • Altis Biosystems, Inc.
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • BellBrook Labs
  • Cellink by Bico Group
  • CN Bio Innovations Limited
  • Copner BIoTech
  • Corning Inc.
  • Curesponse Ltd.
  • Electrospinning Company Ltd.
  • Emulate, Inc.
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • InSphero AG
  • JSR Corporation
  • Known Medicine
  • Lonza Group AG
  • MEGAROBO Technologies Co., Ltd.
  • Merck KGaA
  • MIMETAS
  • Ovizio Imaging Systems SA/NV
  • PELOBIOTECH GmbH
  • Promega Corporation
  • PromoCell GmbH
  • Reprocell Inc.
  • SARSTEDT AG & Co. KG
  • Spiderwort Inc.
  • Synthecon Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • TissUse GmbH
  • TreeFrog Therapeutics SAS
Product Code: MRR-43649B5EE3E5

The 3D Cell Culture Market was valued at USD 1.90 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 7.63%, to USD 3.19 billion by 2030.

3D cell culture, an innovative technique for growing biological cells in a way that closely mimics an in vivo environment, is critical for advancing biomedical research. Its necessity is underlined by its ability to provide more accurate predictive data in drug discovery, cancer research, and tissue engineering compared to traditional 2D cultures. Applications of 3D cell culture span pharmaceutical development, genetic studies, regenerative medicine, and personalized therapy. End-use sectors include biotechnology, academic institutions, hospitals, and diagnostic laboratories. The rise of chronic diseases and advancements in cell culture technology are key factors driving market growth. Additionally, the increasing adoption of 3D cultures in oncology research to study tumor environments offers substantial growth opportunities. The latest potential in the market includes developing organ-on-chip models and microfluidics tech that can revolutionize drug discovery and testing by providing more reliable and ethical alternatives to animal testing. However, limitations such as high costs, technical complexity, and lack of standardized protocols present significant barriers to market growth. Moreover, the requirement for specialized personnel to interpret complex data remains a challenge. Best areas of innovation include the exploration of scaffold-free systems and the integration of artificial intelligence to enhance data analysis and predictive modeling. Research into novel biomaterials for scaffolds and enhanced imaging techniques could further expand the market. Investors and companies should focus on strategic partnerships with academic institutions for cutting-edge innovation and invest in scalable technologies to lower costs. Overall, the 3D cell culture market is characterized by rapid evolution and competitive innovation, necessitating agility and forward-thinking strategies for businesses to leverage emerging trends and drive growth. Companies that can navigate the complexities and offer comprehensive solutions will be well-positioned to capitalize on the expanding market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.90 billion
Estimated Year [2024] USD 2.04 billion
Forecast Year [2030] USD 3.19 billion
CAGR (%) 7.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Cell Culture Market

The 3D Cell Culture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing emphasis on regenerative medicine worldwide
    • Adoption of 3D cell culture for drug resistance and drug repositioning
    • Increasing R&D activities and investments in cell-based studies
  • Market Restraints
    • High cost and complex infrastructure requirements for 3D cell culture development
  • Market Opportunities
    • Advancements in 3D cell culture technologies to support precision medicine
    • Emerging awareness and adoption of organ-on-a-chip models
  • Market Challenges
    • Limited scalability and lack of standardization of 3D cell culture

Porter's Five Forces: A Strategic Tool for Navigating the 3D Cell Culture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Cell Culture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Cell Culture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Cell Culture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Cell Culture Market

A detailed market share analysis in the 3D Cell Culture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Cell Culture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Cell Culture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Cell Culture Market

A strategic analysis of the 3D Cell Culture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, MEGAROBO Technologies Co., Ltd., Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PELOBIOTECH GmbH, Promega Corporation, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc., TissUse GmbH, and TreeFrog Therapeutics SAS.

Market Segmentation & Coverage

This research report categorizes the 3D Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture, Scaffold-based 3D Cell Culture, and Scaffold-free 3D Cell Culture.
  • Based on Application, market is studied across Cancer, Drug Discovery, Stem Cell Research, Tissue Engineering & Regenerative Medicine, and Toxicology.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing emphasis on regenerative medicine worldwide
      • 5.1.1.2. Adoption of 3D cell culture for drug resistance and drug repositioning
      • 5.1.1.3. Increasing R&D activities and investments in cell-based studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complex infrastructure requirements for 3D cell culture development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in 3D cell culture technologies to support precision medicine
      • 5.1.3.2. Emerging awareness and adoption of organ-on-a-chip models
    • 5.1.4. Challenges
      • 5.1.4.1. Limited scalability and lack of standardization of 3D cell culture
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging adoption of scaffold-free 3D cell culture owing to their qualitative benefits and functionalities
    • 5.2.2. Application: Rising application of 3D cell cultures in drug discovery to maintain drug efficacy
    • 5.2.3. End-User: Adoption of 3D cell culture technology in research labs for understanding cell behavior
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. 3D Bio Printing
  • 6.3. Magnetic Levitation
  • 6.4. Microfluidics-based 3D Cell Culture
  • 6.5. Scaffold-based 3D Cell Culture
  • 6.6. Scaffold-free 3D Cell Culture

7. 3D Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Drug Discovery
  • 7.4. Stem Cell Research
  • 7.5. Tissue Engineering & Regenerative Medicine
  • 7.6. Toxicology

8. 3D Cell Culture Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Laboratories & Institutes

9. Americas 3D Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Amsbio Introduces mCollaFibR: Innovations in 3D Cell Culture
    • 12.3.2. Fujifilm Announces USD 1.2 Billion Expansion in North Carolina for Enhanced Cell Culture Capacities
    • 12.3.3. Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
    • 12.3.4. InSphero and Advanced BioMatrix Signed a Distribution Agreement to Expand the Application Range in 3D Cell Culture Into Scaffold-Based Models
    • 12.3.5. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Biotek, LLC
  • 2. Altis Biosystems, Inc.
  • 3. Avantor, Inc.
  • 4. Becton, Dickinson and Company
  • 5. BellBrook Labs
  • 6. Cellink by Bico Group
  • 7. CN Bio Innovations Limited
  • 8. Copner Biotech
  • 9. Corning Inc.
  • 10. Curesponse Ltd.
  • 11. Electrospinning Company Ltd.
  • 12. Emulate, Inc.
  • 13. Greiner Bio-One International GmbH
  • 14. Hamilton Company
  • 15. InSphero AG
  • 16. JSR Corporation
  • 17. Known Medicine
  • 18. Lonza Group AG
  • 19. MEGAROBO Technologies Co., Ltd.
  • 20. Merck KGaA
  • 21. MIMETAS
  • 22. Ovizio Imaging Systems SA/NV
  • 23. PELOBIOTECH GmbH
  • 24. Promega Corporation
  • 25. PromoCell GmbH
  • 26. Reprocell Inc.
  • 27. SARSTEDT AG & Co. KG
  • 28. Spiderwort Inc.
  • 29. Synthecon Inc.
  • 30. Tecan Trading AG
  • 31. Thermo Fisher Scientific, Inc.
  • 32. TissUse GmbH
  • 33. TreeFrog Therapeutics SAS

LIST OF FIGURES

  • FIGURE 1. 3D CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. 3D CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D CELL CULTURE MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D CELL CULTURE MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D CELL CULTURE MARKET SIZE, BY MICROFLUIDICS-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-FREE 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D CELL CULTURE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL 3D CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL 3D CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D CELL CULTURE MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023